Digital Therapeutics in Mental Health Market to Reach US$15.16Bn by 2033, Growing at 19.6% CAGR | Top Companies are BigHealth, Click Therapeutics, Inc., Welldoc, Inc

Digital Therapeutics in Mental Health Market Size and Forecast

DataM Intelligence has published a new research report on "Digital Therapeutics in Mental Health Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/digital-therapeutics-in-mental-health-market?rk

➢ Recent Funding Rounds:

Affect Therapeutics: $26M Series B (Nov 2025), led by Allumia Ventures, for digital mental health/SUD app integrating therapy, meds, and gamification; serves 8 US states.​

CareLoop Health: £1.8M seed (Feb 2025), co-led by GMC Life Sciences and Verge HealthTech, to expand predictive DTx for schizophrenia, psychosis, and bipolar.​

Ellipsis Health: $45M Series A (Jun 2025) for AI voice biomarker tech detecting mental health signals in speech.​

➢ AI and Chatbot Innovations:

AI-powered chatbots like Therabot deliver personalized CBT, showing significant symptom reductions in MDD, GAD, and eating disorders via recent RCTs.​

Generative AI apps enhance conventional depression treatments, with meta-analyses confirming small but robust effects when augmented with standard care.​

VR and Immersive Tech
VR-based DTx augment CBT for anxiety, PTSD, and phobias, providing exposure therapy in controlled digital environments with promising secondary outcomes.

Hybrid and Continuous Care:
Hybrid models combine in-person evals with virtual follow-ups, using wearables for real-time mood/sleep tracking to enable early interventions and reduce relapses.​

FDA-cleared DTx now total 13+ by mid-2025, including expansions for chronic conditions like cognitive impairments, with payer reimbursements growing.​

➢ Blended Interventions:

Human-supported digital tools yield better results in schizophrenia, improving adherence, symptoms, and cognition; apps like SlowMo show promise in secondary outcomes.​

Switzerland mandates reimbursement for certified mental health apps targeting mild-moderate depression starting July 2026, boosting access via national insurance.

Key players like MindMaze, Big Health, and Otsuka drive growth through partnerships and enterprise solutions, focusing on AI-personalized CBT for depression and insomnia.​

Swing Therapeutics and GrayMatters Health expand FDA-cleared platforms with neurotech integrations for anxiety and cognitive support.​

➢ Recent Deals:

LifeStance Health eyes disciplined tuck-in acquisitions for DTx and specialty services to accelerate hybrid care strategies, per Q1 2025 earnings outlook.​

KOO (AIM-listed) expanded into US digital mental health via acquiring Kismet Health, a virtual patient platform, boosting its global footprint.​

➢ Predicted Trends:

Expect mergers between mental health tech firms and employee benefits providers, like potential Spring Health deals, for diversified revenue.​

Consolidation wave anticipated as "zombie" startups face down rounds; AI scribes and EHR integrations become prime acqui-hire targets.

➢ Key Players:

BigHealth, Click Therapeutics, Inc., Welldoc, Inc., 2Morrow Inc., Mindscapes, Calm.com, Inc., MoodMission Pty Ltd, Boehringer Ingelheim Pharmaceuticals, Inc., Headspace Inc., and Happify, Inc.

➢ Growth Forecast Projected:

The Global Digital Therapeutics in Mental Health Market is anticipated to rise at a considerable rate during the forecast period, between 2025 and 2032. In 2024, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

Research Process:

Both primary and secondary data sources have been used in the global Digital Therapeutics in Mental Health Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=digital-therapeutics-in-mental-health-market?rk

➢ Key Segments:

By Type:
The market is segmented by type into software-based digital therapeutics, hardware-integrated digital therapeutics, and sensor-based digital therapeutics. Software-based digital therapeutics dominate the segment as they are easily accessible through mobile apps and web platforms, enabling scalable and cost-effective mental health interventions. Hardware-integrated digital therapeutics combine software with devices such as wearables or neurostimulation tools to deliver more targeted and measurable outcomes. Sensor-based digital therapeutics leverage real-time physiological and behavioral data to personalize treatment pathways and improve clinical effectiveness.

By Application:
By application, the market includes depression & mood disorders, anxiety disorders, post-traumatic stress disorder (PTSD), obsessive-compulsive disorder (OCD), schizophrenia & psychotic disorders, sleep disorders & insomnia, substance use disorders, attention-deficit/hyperactivity disorder (ADHD), and others. Depression and anxiety disorders account for a major share due to their high global prevalence and growing acceptance of digital mental health solutions. PTSD, OCD, and schizophrenia-related applications are expanding with increasing clinical validation of digital interventions. Sleep disorders, substance use disorders, and ADHD are gaining traction as digital therapeutics offer continuous monitoring, behavioral modification, and personalized care, while the "others" segment includes emerging applications across stress management and cognitive health.

Regional Analysis for Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Benefits of the Report:

Chapter 1: Lays the foundation by defining the scope of the report, highlighting core market segments across regions, product types, and applications. It delivers a clear snapshot of current market size, growth potential, and how the industry is expected to evolve in both the near and long term.

Chapter 2: Spotlights the most impactful market insights, unveiling the transformative trends and forces shaping the future of the industry.

Chapter 3: Provides a deep dive into the competitive landscape of , covering revenue shares, strategic initiatives, and notable mergers & acquisitions that are reshaping the market.

Chapter 4: Presents detailed company profiles of leading players featuring financial performance, product portfolios, profit margins, and key milestones that set them apart in the industry.

Chapters 5 & 6: Break down revenue analysis at both regional and country levels, offering precise data on market size, growth drivers, and expansion opportunities across global markets.

Chapter 7: Analyzes the market by product type, spotlighting segment-specific opportunities and helping stakeholders identify untapped, high-growth areas.

Chapter 8 :Explores the market through application-based segmentation, assessing demand across industries and pinpointing downstream sectors with the strongest potential for growth.

Chapter 9: Maps the industry's supply chain in detail, tracing upstream and downstream activities to provide clarity on value creation across the ecosystem.

Chapter 10: Wraps up with a concise summary of the report's key insights distilling the most critical findings and strategic takeaways for decision-makers and stakeholders.

Get Customization in the report as per your requirements: https://datamintelligence.com/customize/digital-therapeutics-in-mental-health-market?rk

FAQ

Q1: What is the current size of the Digital Therapeutics in Mental Health Market?

A: The Digital Therapeutics in Mental Health Market size reached US$ 3.07 billion in 2024 and is expected to reach US$ 15.16 billion by 2033.

Q2: How rapidly will the Market expand?

A: The Digital Therapeutics in Mental Health market is projected to grow at a CAGR of 19.6% between 2025 and 2033.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?rk

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg?rk

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.